Whitepaper

Rethinking medtech in Covid times Whitepaper
Can MedTech adapt to the new distanced world of COVID-19?
Rethinking medtech in Covid times

More Whitepapers / Newsletters

Pompe Disease Newsletter
Pompe Disease

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen in muscle and nerve cells throughout the body. Also c...

Lamellar Ichthyosis
Lamellar Ichthyosis

Lamellar Ichthyosis (LI) is an autosomal recessive congenital Ichthyosis (ARCI), which mainly affects the skin. It is a clinically and genetically heterogeneous group of dermatological scaly skin diso...

Digital Therapeutics In Mental Health Whitepaper
Digital Therapeutics In Mental...

Digital therapies are evidence-based clinical approaches powered by software applications designed to prevent, control or treat a particular disease or condition. While advances in technology-assisted...

Rethinking medtech in Covid times
Rethinking medtech in Covid ti...

COVID-19 transforms healthcare facets at an unprecedented pace. Based on emerging technology, we can be reasonably sure that the bulk of the change will be powered by the digital transformation made p...

Hospital-Acquired Bacterial Pneumonia/ Ventilator-Associated Bacterial Pneumonia
Hospital-Acquired Bacterial Pn...

Hospital-acquired bacterial pneumonia (HABP) is the most common type of health-care-associated infections (HAIs) and hospital-acquired infections. It is often seen in patients admitted to ICU wards. A...